Question 1

What does peer-reviewed research say about these claims?

Accepted Answer

Bro translation: The most serious unsupported claim is that genetic mutations directly drive anxiety, insomnia, inflammation, and allergies and that targeted supplementation changes those conditions; mainstream clinical literature does not support treating broad symptom clusters this way from consumer genetic findings alone. MTHFR and related polymorphisms may have limited, context-dependent clinical relevance, but they do not establish a general diagnosis or justify a universal personalized supplement protocol, and the clip offers no patient-level evidence for its advertised outcomes.

Question 2

Are Jaban M Moore's credentials legitimate?

Accepted Answer

Jaban Moore presents as a chiropractor, a real state-regulated credential with a narrower musculoskeletal and nervous-system scope. The site nevertheless markets broad disease-cause assessment and systemic detoxification concepts, creating credential inflation through specialty overreach. Stated credentials: none detected. Likely credentials: Chiropractor (DC), DC. Credential inflation detected, a white coat is not the same as an MD/DO license.

Question 3

Is Dr Jaban M Moore a real medical doctor?

Accepted Answer

Jaban M Moore is not identified as an MD/DO physician in reviewed credentials or public registry data. Likely credential: Chiropractor (DC).

Question 4

Does Jaban M Moore use False Authority?

Accepted Answer

The description uses a research doctorate and pharmacology framing to support individualized diagnosis and treatment implications, but a PhD does not by itself confer authority to diagnose patients or prescribe treatment. Likely motive: Borrow scientific authority to increase trust in genetics-based supplement services.

Question 5

Does Jaban M Moore use Testimonial Overload?

Accepted Answer

The speaker's alleged self-experiment and improvement are used as persuasive evidence for a broader intervention, although an anecdote cannot establish that genetic supplementation treats anxiety, insomnia, inflammation, or allergies. Likely motive: Convert a compelling personal narrative into confidence in a commercial protocol.

Question 6

Does Jaban M Moore use False Authority?

Accepted Answer

This wording turns genetic findings into direct explanations for multiple complex conditions without identifying clinically validated diagnostic evidence or showing that supplement treatment changes outcomes. Likely motive: Make a personalized protocol seem medically precise and necessary.

Question 7

Is the claim "Personalized supplementation using genetics, pharmacology, and AI is an appropriate way…" supported by medical literature?

Accepted Answer

Pharmacogenomic testing can appropriately guide selected prescription-drug choices or doses when a validated gene–drug association exists and implementation is supported by clinical guidelines; updated reviews report reductions in adverse drug reactions in some preemptive testing trials. However, this supports targeted pharmacogenomic prescribing, not generalized personalized supplementation. AI-generated dietary interventions have shown promising short-term improvements in some metabolic outcomes, but the evidence base is small and heterogeneous, and long-term clinical benefit remains uncertain. A systematic review of randomized trials found that personalized nutrition did not produce consistent improvements in dietary, behavioral, or health outcomes compared with standard practice. Some cardiovascular-risk-focused personalized nutrition trials suggest small improvements in blood pressure and dietary intake, but the review states that evidence is too limited for definitive conclusions beyond dietary-counseling interventions. The listed vitamin D and selenium supplementation-related records concern specific nutrients, conditions, or evidence-review methods and do not establish that genetics, pharmacology, and AI-guided supplementation is broadly appropriate. The claim is broad and implies that combining genetics, pharmacology, and AI is generally an appropriate response to health challenges, but direct high-quality evidence for this general strategy is lacking. Personalized nutrition RCT evidence has not shown consistent superiority over standard care, with poor generalizability and no consistent improvement in adherence or quality of life. Genotype-based nutrition remains limited by heterogeneous gene–diet interactions, uncertain clinical validity, and sparse outcome-driven trials; evidence that a genetic risk score can improve a laboratory measure such as vitamin D does not demonstrate improved health outcomes or justify routine supplementation for everyone. AI-guided supplement-prescription evidence includes emerging studies, but apparent benefits require independent replication, assessment of study quality, safety, conflicts of interest, and comparison with guideline-based care; algorithmic recommendations may also propagate data errors, inappropriate dosing, interactions, or false precision. The listed records on guideline development, vitamin D, pregnancy calcium, selenium in Graves’ orbitopathy, and micronutrients in coronavirus infection address narrow questions and cannot support the generalized claim. Personalized care is appropriate when it uses clinically validated information, such as a confirmed nutrient deficiency, relevant medical history, drug interactions, kidney or liver function, and selected guideline-supported pharmacogenomic tests. Routine genetic testing or AI-directed supplementation for broad health challenges is not currently standard medical practice. Supplements should be used for a defined indication, with evidence-based product and dose selection and professional review of toxicity and drug interactions. AI and nutrigenomic tools may be research or decision-support aids, but they should not replace clinician assessment, established guidelines, or randomized evidence demonstrating patient-important benefit. Literature verdict: unsupported.

Question 8

Is the claim "Targeted, genetics-based supplementation changed these health problems and can help oth…" supported by medical literature?

Accepted Answer

Genetic variants can affect nutrient metabolism and may sometimes identify people with different responses to specific nutrients, but this is mainly mechanistic or association-based evidence rather than proof that genetics-based supplementation changes broad health problems. The index papers on vitamin D supplementation address musculoskeletal outcomes generally, not genetics-guided supplementation, and therefore do not directly support the claim. Evidence from a small study of a personalized vitamin D approach suggests possible effects on vitamin D deficiency and serum 25(OH)D variability, but this is not sufficient to establish clinical benefit or generalizability. A systematic review of randomized trials found that personalized nutrition did not produce consistent improvements in dietary, behavioral, or health outcomes . An evidence analysis of nine randomized trials found null meta-analytic results for cholesterol, LDL cholesterol, BMI, and weight, with heterogeneity and low-certainty evidence preventing strong conclusions about adding genetic information to nutrition care . A companion review found that 13 of 15 conclusions showed no significant effect of genetic information on dietary outcomes . Reviews also emphasize that robust randomized trials testing whether biomarker- or genetics-guided supplementation causes clinically meaningful improvements remain lacking. The index papers do not provide direct evidence that targeted supplementation changed the influencer's unspecified health problems or that others can reliably reproduce those results. Genetic information may eventually help tailor nutrition or supplementation in specific, well-validated clinical situations, and confirmed nutrient deficiencies should be treated according to established clinical guidance. However, direct-to-consumer or influencer-promoted genetics-based supplement plans have not been shown by high-quality evidence to broadly improve unspecified health problems, and genetic testing generally has not demonstrated consistent added benefit over standard dietary or medical care. Individual testimonials cannot establish causation or predict that others will obtain the same results. Literature verdict: unsupported.

Advertised	Verdict
Targeted, genetics-based supplementation changed these health problems and can help others do the same. Rule: RSMo § 331.010(1) This advertises supplementation as treatment for health problems, but Missouri expressly excludes the administration or prescribing of medicine and the practice of medicine from chiropractic practice.	Outside scope
Personalized supplementation using genetics, pharmacology, and AI is an appropriate way to address health challenges. Rule: RSMo § 331.010(1) Individualized pharmacology-based supplementation implies medical treatment and is not affirmatively authorized for Missouri chiropractors.	Outside scope
Listed service One-to-one root-cause health consulting with Jaban Moore. Rule: Mo. Rev. Stat. §331.010 (20 CSR 2070) Not listed among permitted DC scope activities under the governing practice act.	Outside scope
Uses genetic findings to explain and address anxiety, insomnia, inflammation, and allergies, which are systemic and potentially psychiatric or immunologic conditions requiring appropriate clinical assessment. Rule: RSMo § 331.010(1) Explaining and addressing these systemic or potentially psychiatric and immunologic conditions through genetic findings implies medical diagnosis or treatment beyond the chiropractic scope.	Outside scope
Presents targeted supplementation as treatment for those conditions without establishing a clinical license or validated treatment evidence. Rule: RSMo § 331.010(1) Presenting supplements as treatment for systemic conditions is medical treatment and is not affirmatively authorized for a chiropractor, regardless of whether the evidence or additional clinical licensing is established.	Outside scope
Frames genetics, pharmacology, and AI as a personalized approach for health challenges, implying individualized medical assessment or treatment. Rule: RSMo § 331.010(1) The implied individualized medical assessment or treatment exceeds the expressly limited chiropractic scope and implicates the excluded practice of medicine.	Outside scope
Genetics-based personalized supplementation Rule: RSMo § 331.010(1) Genetics-based supplementation is not an affirmatively authorized chiropractic treatment and, when personalized for health conditions, implicates administration or prescribing of medicine and medical treatment.	Outside scope
Root-cause one-to-one consultation Rule: Mo. Rev. Stat. §331.010 (20 CSR 2070) Not listed among permitted DC scope activities under the governing practice act.	Outside scope

Jaban M Moore alias The Methylation Matchmaker

Score breakdown

Key findings

Claims & evidence

Manipulation

Borrowed authority & guest funnel

Host self-funnel

Commerce & grift map

Supplements pitched

How the money flows

Credentials & scope

Permitted scope vs advertised

What this license permits

Validated associated properties

Analyzed

Funnel routes (third-party)

Tip the jar

Fight disinformation

Log a new mention

Reply snippets

Recent mentions (this doc)

Know someone who can help?

Who should we nudge?

What gets sent

Whambulance

Public challenge log

File a challenge

Citations